Table of Content

1 Vaccine for Influenza Market Overview
1.1 Product Overview and Scope of Vaccine for Influenza
1.2 Vaccine for Influenza Segment by Type
1.2.1 Global Vaccine for Influenza Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Vaccine for Influenza Segment by Application
1.3.1 Vaccine for Influenza Sales Comparison by Application: (2021-2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Vaccine for Influenza Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Influenza Revenue 2016-2027
1.4.2 Global Vaccine for Influenza Sales 2016-2027
1.4.3 Vaccine for Influenza Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vaccine for Influenza Market Competition by Manufacturers
2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2016-2021)
2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Vaccine for Influenza Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
2.5 Vaccine for Influenza Market Competitive Situation and Trends
2.5.1 Vaccine for Influenza Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vaccine for Influenza Players Market Share by Revenue
2.5.3 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vaccine for Influenza Retrospective Market Scenario by Region
3.1 Global Vaccine for Influenza Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Vaccine for Influenza Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Vaccine for Influenza Market Facts & Figures by Country
3.3.1 North America Vaccine for Influenza Sales by Country
3.3.2 North America Vaccine for Influenza Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccine for Influenza Market Facts & Figures by Country
3.4.1 Europe Vaccine for Influenza Sales by Country
3.4.2 Europe Vaccine for Influenza Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccine for Influenza Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccine for Influenza Sales by Region
3.5.2 Asia Pacific Vaccine for Influenza Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccine for Influenza Market Facts & Figures by Country
3.6.1 Latin America Vaccine for Influenza Sales by Country
3.6.2 Latin America Vaccine for Influenza Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccine for Influenza Sales by Country
3.7.2 Middle East and Africa Vaccine for Influenza Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Vaccine for Influenza Historic Market Analysis by Type
4.1 Global Vaccine for Influenza Sales Market Share by Type (2016-2021)
4.2 Global Vaccine for Influenza Revenue Market Share by Type (2016-2021)
4.3 Global Vaccine for Influenza Price by Type (2016-2021)

5 Global Vaccine for Influenza Historic Market Analysis by Application
5.1 Global Vaccine for Influenza Sales Market Share by Application (2016-2021)
5.2 Global Vaccine for Influenza Revenue Market Share by Application (2016-2021)
5.3 Global Vaccine for Influenza Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CSL Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GSK Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hulan Bio Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
6.6.4 AstraZeneca Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description and Business Overview
6.6.3 CCBIO Vaccine for Influenza Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CCBIO Product Portfolio
6.7.5 CCBIO Recent Developments/Updates

7 Vaccine for Influenza Manufacturing Cost Analysis
7.1 Vaccine for Influenza Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccine for Influenza
7.4 Vaccine for Influenza Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccine for Influenza Distributors List
8.3 Vaccine for Influenza Customers

9 Vaccine for Influenza Market Dynamics
9.1 Vaccine for Influenza Industry Trends
9.2 Vaccine for Influenza Growth Drivers
9.3 Vaccine for Influenza Market Challenges
9.4 Vaccine for Influenza Market Restraints

10 Global Market Forecast
10.1 Vaccine for Influenza Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Vaccine for Influenza by Type (2022-2027)
10.2 Vaccine for Influenza Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccine for Influenza by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Vaccine for Influenza by Application (2022-2027)
10.3 Vaccine for Influenza Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccine for Influenza by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Vaccine for Influenza by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaccine for Influenza Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Vaccine for Influenza Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Vaccine for Influenza Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Vaccine for Influenza Covered in This Study
Table 5. Global Vaccine for Influenza Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Vaccine for Influenza Sales Share by Manufacturers (2016-2021)
Table 7. Global Vaccine for Influenza Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Vaccine for Influenza Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Vaccine for Influenza Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Vaccine for Influenza Manufacturing Sites and Area Served
Table 11. Manufacturers Vaccine for Influenza Product Type
Table 12. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Influenza as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Vaccine for Influenza Sales by Region (2016-2021) & (K Units)
Table 16. Global Vaccine for Influenza Sales Market Share by Region (2016-2021)
Table 17. Global Vaccine for Influenza Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Vaccine for Influenza Sales by Country (2016-2021) & (K Units)
Table 19. North America Vaccine for Influenza Sales Market Share by Country (2016-2021)
Table 20. North America Vaccine for Influenza Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Vaccine for Influenza Revenue Market Share by Country (2016-2021)
Table 22. Europe Vaccine for Influenza Sales by Country (2016-2021) & (K Units)
Table 23. Europe Vaccine for Influenza Sales Market Share by Country (2016-2021)
Table 24. Europe Vaccine for Influenza Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Vaccine for Influenza Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Vaccine for Influenza Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Vaccine for Influenza Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Vaccine for Influenza Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Vaccine for Influenza Revenue Market Share by Region (2016-2021)
Table 30. Latin America Vaccine for Influenza Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Vaccine for Influenza Sales Market Share by Country (2016-2021)
Table 32. Latin America Vaccine for Influenza Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Vaccine for Influenza Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Vaccine for Influenza Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Vaccine for Influenza Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Vaccine for Influenza Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Vaccine for Influenza Revenue Market Share by Country (2016-2021)
Table 38. Global Vaccine for Influenza Sales (K Units) by Type (2016-2021)
Table 39. Global Vaccine for Influenza Sales Market Share by Type (2016-2021)
Table 40. Global Vaccine for Influenza Revenue (Million US$) by Type (2016-2021)
Table 41. Global Vaccine for Influenza Revenue Share by Type (2016-2021)
Table 42. Global Vaccine for Influenza Price (US$/Unit) by Type (2016-2021)
Table 43. Global Vaccine for Influenza Sales (K Units) by Application (2016-2021)
Table 44. Global Vaccine for Influenza Sales Market Share by Application (2016-2021)
Table 45. Global Vaccine for Influenza Revenue (Million US$) by Application (2016-2021)
Table 46. Global Vaccine for Influenza Revenue Share by Application (2016-2021)
Table 47. Global Vaccine for Influenza Price (US$/Unit) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi Vaccine for Influenza Product
Table 52. Sanofi Recent Developments/Updates
Table 53. CSL Corporation Information
Table 54. CSL Description and Business Overview
Table 55. CSL Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. CSL Vaccine for Influenza Product
Table 57. CSL Recent Developments/Updates
Table 58. GSK Corporation Information
Table 59. GSK Description and Business Overview
Table 60. GSK Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. GSK Vaccine for Influenza Product
Table 62. GSK Recent Developments/Updates
Table 63. Mylan Corporation Information
Table 64. Mylan Description and Business Overview
Table 65. Mylan Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Mylan Vaccine for Influenza Product
Table 67. Mylan Recent Developments/Updates
Table 68. Hulan Bio Corporation Information
Table 69. Hulan Bio Description and Business Overview
Table 70. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Hulan Bio Vaccine for Influenza Product
Table 72. Hulan Bio Recent Developments/Updates
Table 73. AstraZeneca Corporation Information
Table 74. AstraZeneca Description and Business Overview
Table 75. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. AstraZeneca Vaccine for Influenza Product
Table 77. AstraZeneca Recent Developments/Updates
Table 78. CCBIO Corporation Information
Table 79. CCBIO Description and Business Overview
Table 80. CCBIO Vaccine for Influenza Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. CCBIO Vaccine for Influenza Product
Table 82. CCBIO Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Vaccine for Influenza Distributors List
Table 86. Vaccine for Influenza Customers List
Table 87. Vaccine for Influenza Market Trends
Table 88. Vaccine for Influenza Growth Drivers
Table 89. Vaccine for Influenza Market Restraints
Table 90. Global Vaccine for Influenza Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Vaccine for Influenza Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Vaccine for Influenza Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Vaccine for Influenza Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Vaccine for Influenza Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Vaccine for Influenza Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Vaccine for Influenza Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Vaccine for Influenza Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Vaccine for Influenza Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Vaccine for Influenza Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Vaccine for Influenza Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine for Influenza
Figure 2. Global Vaccine for Influenza Market Share by Type in 2020 & 2027
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Vaccine for Influenza Market Share by Application in 2020 & 2027
Figure 6. For Children (6 months to 3 years)
Figure 7. For Adults and Children over 3 years
Figure 8. Global Vaccine for Influenza Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Vaccine for Influenza Market Size 2016-2027 (US$ Million)
Figure 10. Global Vaccine for Influenza Sales 2016-2027 (K Units)
Figure 11. Global Vaccine for Influenza Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Vaccine for Influenza Sales Share by Manufacturers in 2020
Figure 13. Global Vaccine for Influenza Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Vaccine for Influenza Players: Market Share by Revenue in 2020
Figure 15. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Vaccine for Influenza Sales Market Share by Region (2016-2021)
Figure 17. Global Vaccine for Influenza Sales Market Share by Region in 2020
Figure 18. Global Vaccine for Influenza Revenue Market Share by Region (2016-2021)
Figure 19. Global Vaccine for Influenza Revenue Market Share by Region in 2020
Figure 20. U.S. Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Vaccine for Influenza Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Vaccine for Influenza by Type (2016-2021)
Figure 45. Sales Market Share of Vaccine for Influenza by Application (2016-2021)
Figure 46. Sales Market Share of Vaccine for Influenza by Application in 2020
Figure 47. Revenue Share of Vaccine for Influenza by Application (2016-2021)
Figure 48. Revenue Share of Vaccine for Influenza by Application in 2020
Figure 49. Manufacturing Cost Structure of Vaccine for Influenza
Figure 50. Manufacturing Process Analysis of Vaccine for Influenza
Figure 51. Vaccine for Influenza Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed